Key facts
- This page summarizes Charles J. Dockendorff's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 May 2024, 16:36.
Charles J. Dockendorff - 09 May 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)
- Reporting relationship
- Director
- Issuer ticker
- BSX
- Reported as of
- 09 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 May 2024, 16:36:15 UTC
- Prior SEC filing
- 08 May 2024
- Next SEC filing
- 26 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Susan Thompson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles J. Dockendorff filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 13 May 2024.
Change
- Previous filing in this sequence was filed on 08 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,901
- Change %
- Price
- $0.000000
- Shares after
- 2,901
- Date
- 09 May 2024
- Ownership
- Direct
- Footnotes
- F1
BSX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 42,622
- Date
- 09 May 2024
- Ownership
- By Spouse's Trust
BSX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,380
- Date
- 09 May 2024
- Ownership
- By Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $215,000 divided by the closing price of common stock on the date of grant.